VAFNX
Price
$31.82
Change
+$0.40 (+1.27%)
Updated
Dec 20 closing price
VIGIX
Price
$214.82
Change
+$2.24 (+1.05%)
Updated
Dec 20 closing price
Ad is loading...

VAFNX vs VIGIX

Header iconVAFNX vs VIGIX Comparison
Open Charts VAFNX vs VIGIXBanner chart's image
Invesco American Franchise R5
Price$31.82
Change+$0.40 (+1.27%)
VolumeN/A
CapitalizationN/A
Vanguard Growth Index Institutional
Price$214.82
Change+$2.24 (+1.05%)
VolumeN/A
CapitalizationN/A
VAFNX vs VIGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VAFNX vs. VIGIX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VAFNX is a StrongBuy and VIGIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VIGIX has more cash in the bank: 282B vs. VAFNX (17.2B). VIGIX pays higher dividends than VAFNX: VIGIX (0.53) vs VAFNX (0.00). VAFNX was incepted earlier than VIGIX: VAFNX (14 years) vs VIGIX (27 years). VAFNX is a more actively managed with annual turnover of: 73.00 vs. VIGIX (5.00). VAFNX has a lower initial minimum investment than VIGIX: VAFNX (1000000) vs VIGIX (5000000). VIGIX (34.37) and VAFNX (32.92) have marching annual gain over last year. VIGIX return over 5 years is better than : 129.76 vs. VAFNX (40.49).
VAFNXVIGIXVAFNX / VIGIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years27 years-
Gain YTD32.52834.27295%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets17.2B282B6%
Annual Yield % from dividends0.000.53-
Returns for 1 year32.9234.3796%
Returns for 3 years21.8232.7767%
Returns for 5 years40.49129.7631%
Returns for 10 years88.40298.5830%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCL238.437.67
+3.32%
Royal Caribbean Group
ATUS2.640.08
+3.13%
Altice USA
CCCC3.950.11
+2.73%
C4 Therapeutics
PFSI101.661.56
+1.56%
PennyMac Financial Services
ELEV0.58-0.05
-7.30%
Elevation Oncology